Search

Your search keyword '"Kasahara, Kohei"' showing total 48 results
Start Over Author "Kasahara, Kohei"
48 results on '"Kasahara, Kohei"'

1. Cyclic Triaxial Test of Existing Embankment Material Under Repeated Train Load on Condition of Damage by Rainfall

Author

Matsumaru, Takaki, Sato, Taketo, Kasahara, Kohei, Ozaki, Takumi, di Prisco, Marco, Series Editor, Chen, Sheng-Hong, Series Editor, Vayas, Ioannis, Series Editor, Kumar Shukla, Sanjay, Series Editor, Sharma, Anuj, Series Editor, Kumar, Nagesh, Series Editor, Wang, Chien Ming, Series Editor, Cui, Zhen-Dong, Series Editor, Lu, Xinzheng, Series Editor, Rujikiatkamjorn, Cholachat, editor, Xue, Jianfeng, editor, and Indraratna, Buddhima, editor

Published
2025
Full Text
View/download PDF

3. Is Prophylactic Splenectomy Necessary for Proximal Advanced Gastric Cancer Invading the Greater Curvature with Clinically Negative Splenic Hilar Lymph Node Metastasis? A Multi-Institutional Cohort Study (YCOG2003)

Author

Sato, Sho, Kunisaki, Chikara, Kondo, Hiroki, Tsuchiya, Nobuhiro, Tanaka, Yusaku, Takahashi, Masazumi, Sato, Kei, Kimura, Jun, Ono, Hidetaka A., Makino, Hirochika, Tamura, Yuko, Kasahara, Kohei, Kosaka, Takashi, Akiyama, Hirotoshi, and Endo, Itaru

Published
2022
Full Text
View/download PDF

5. High postoperative neutrophil–lymphocyte ratio and low preoperative lymphocyte-monocyte ratio predict poor prognosis in gastric cancer patients receiving gastrectomy with positive lavage cytology: a retrospective cohort study

Author

Sato, Sho, Kunisaki, Chikara, Takahashi, Masazumi, Kubo, Hirokazu, Tsuchiya, Nobuhiro, Sato, Kei, Miyamoto, Hiroshi, Tamura, Yuko, Kondo, Hiroki, Tanaka, Yusaku, Kasahara, Kohei, Kosaka, Takashi, Akiyama, Hirotoshi, Saigusa, Yusuke, and Endo, Itaru

Published
2021
Full Text
View/download PDF

8. ASO Visual Abstract: Is Prophylactic Splenectomy Necessary for Proximal Advanced Gastric Cancer Invading the Greater Curvature with Clinically Negative Splenic Hilar Lymph Node Metastasis? A Multi-Institutional Cohort Study (YCOG2003)

Author

Sato, Sho, Kunisaki, Chikara, Kondo, Hiroki, Tsuchiya, Nobuhiro, Tanaka, Yusaku, Takahashi, Masazumi, Sato, Kei, Kimura, Jun, Ono, Hidetaka A., Makino, Hirochika, Tamura, Yuko, Kasahara, Kohei, Kosaka, Takashi, Akiyama, Hirotoshi, and Endo, Itaru

Published
2022
Full Text
View/download PDF

10. Wilms Tumor 1 Expression at Diagnosis Correlates With Genetic Abnormalities and Polymorphism But Is Not Independently Prognostic in Acute Myelogenous Leukemia: A Hokkaido Leukemia Net Study

Author

Hidaka, Daisuke, Onozawa, Masahiro, Hashiguchi, Junichi, Miyashita, Naohiro, Kasahara, Kohei, Fujisawa, Shinichi, Hayase, Eiko, Okada, Kohei, Shiratori, Souichi, Goto, Hideki, Sugita, Junichi, Nakagawa, Masao, Hashimoto, Daigo, Kahata, Kaoru, Endo, Tomoyuki, Yamamoto, Satoshi, Tsutsumi, Yutaka, Haseyama, Yoshihito, Nagashima, Takahiro, Mori, Akio, Ota, Shuichi, Sakai, Hajime, Ishihara, Toshimichi, Imai, Kiyotoshi, Miyagishima, Takuto, Kakinoki, Yasutaka, Kurosawa, Mitsutoshi, Kobayashi, Hajime, Iwasaki, Hiroshi, Shimizu, Chikara, Kondo, Takeshi, and Teshima, Takanori

Published
2018
Full Text
View/download PDF

11. Long-term Outcomes of Neoadjuvant Chemotherapy With Docetaxel, Cisplatin and S-1 for Stage III Gastric Cancer

Author

KASAHARA, KOHEI, primary, KUNISAKI, CHIKARA, additional, SATO, SHO, additional, KONDO, HIROKI, additional, TAKAHASHI, MASAZUMI, additional, TAMURA, YUKO, additional, TSUCHIYA, NOBUHIRO, additional, TANAKA, YUSAKU, additional, SATO, KEI, additional, KIMURA, JUN, additional, KOSAKA, TAKASHI, additional, ONO, HIDETAKA, additional, MAKINO, HIROCHIKA, additional, AKIYAMA, HIROTOSHI, additional, and ENDO, ITARU, additional

Published
2023
Full Text
View/download PDF

14. The preceding hyponatremia is a useful hallmark for the diagnosis of HHV-6 encephalitis after allogeneic hematopoietic stem cell transplantation

Author

Yoshida, Shota, primary, Ara, Takahide, additional, Okada, Kohei, additional, Mori, Yuto, additional, Tsukamoto, Shihori, additional, Miyashita, Naoki, additional, Kasahara, Kohei, additional, Ebata, Ko, additional, Iwasaki, Junko, additional, Takahashi, Shojiro, additional, Shigematsu, Akio, additional, Minauchi, Koichiro, additional, Kobayashi, Naoki, additional, Ogasawara, Masahiro, additional, Imamura, Masahiro, additional, Teshima, Takanori, additional, and Ota, Shuichi, additional

Published
2022
Full Text
View/download PDF

17. Antiretroviral therapy achieved metabolic complete remission of hepatic AIDS related Epstein-Barr virus-associated smooth muscle tumor

Author

Ara, Takahide, primary, Endo, Tomoyuki, additional, Goto, Hideki, additional, Kasahara, Kohei, additional, Hasegawa, Yuta, additional, Yokoyama, Shota, additional, Shiratori, Souichi, additional, Nakagawa, Masao, additional, Kuwahara, Ken, additional, Takakuwa, Emi, additional, Hashino, Satoshi, additional, and Teshima, Takanori, additional

Published
2022
Full Text
View/download PDF

18. The preceding hyponatremia is a useful hallmark for the diagnosis of HHV-6 encephalitis after allogeneic hematopoietic stem cell transplantation

Author

Ara, Takahide, primary, Yoshida, Shota, additional, Okada, Kohei, additional, Mori, Yuto, additional, Tsukamoto, Shihori, additional, Miyashita, Naoki, additional, Kasahara, Kohei, additional, Ebata, Ko, additional, Iwasaki, Junko, additional, Takahashi, Shojiro, additional, Shigematsu, Akio, additional, Minauchi, Koichiro, additional, Kobayashi, Naoki, additional, Ogasawra, Masahiro, additional, Imamur, Masahiro, additional, Teshima, Takanori, additional, and Ota, Shuichi, additional

Published
2022
Full Text
View/download PDF

19. Antiretroviral therapy achieved metabolic complete remission of hepatic AIDS related Epstein-Barr virus-associated smooth muscle tumor

Author

Ara, Takahide, Endo, Tomoyuki, Goto, Hideki, Kasahara, Kohei, Hasegawa, Yuta, Yokoyama, Shota, Shiratori, Souichi, Nakagawa, Masao, Kuwahara, Ken, Takakuwa, Emi, Hashino, Satoshi, Teshima, Takanori, Ara, Takahide, Endo, Tomoyuki, Goto, Hideki, Kasahara, Kohei, Hasegawa, Yuta, Yokoyama, Shota, Shiratori, Souichi, Nakagawa, Masao, Kuwahara, Ken, Takakuwa, Emi, Hashino, Satoshi, and Teshima, Takanori

Abstract

Epstein-Barr virus-associated smooth muscle tumor (EBV-SMT) is a rare mesenchymal tumor which occurs in immunocompromised patients. The immune status is an important factor in the treatment of EBV-SMTs, but the efficacy of antiretroviral therapy (ART) is not elucidated in acquired immune deficiency syndrome (AIDS) related EBV-SMTs. Here, we report the first successful case of a 29-year-old man with hepatic AIDS related EBV-SMT treated with ART solely. Positron emission tomography scan was useful for the evaluation of disease status. Recent advances in ART that enables to restore patient's immune status rapidly may change the treatment strategy in AIDS related EBV-SMT.

Published
2022

26. Nivolumab-induced immune thrombocytopenia in a patient with malignant pleural mesothelioma

Author

Sakakibara-Konishi, Jun, Sato, Mineyoshi, Sato, Michiko Takimoto, Kasahara, Kohei, Onozawa, Masahiro, Mizugaki, Hidenori, Kikuchi, Eiki, Asahina, Hajime, Shinagawa, Naofumi, Konno, Satoshi, Sakakibara-Konishi, Jun, Sato, Mineyoshi, Sato, Michiko Takimoto, Kasahara, Kohei, Onozawa, Masahiro, Mizugaki, Hidenori, Kikuchi, Eiki, Asahina, Hajime, Shinagawa, Naofumi, and Konno, Satoshi

Abstract

Malignant pleural mesothelioma (MPM) is a rare and highly aggressive tumor. Nivolumab showed durable antitumor effect in patients with recurrent MPM and was approved for those patients in Japan in 2018. Immune related adverse event (irAE) is occurred in various organs and is suggestive to be related to better outcome of nivolumab. Frequency of hematological irAE is low and there are few reports about hematological irAE and association between irAE and outcome of nivolumab in patients with MPM. We present a case of recurrent MPM who responded to nivolumab treatment and experienced nivolumab-induced immune thrombocytopenia (ITP). Although high dose dexamethasone was administered and platelet count increased transiently, re-administration of dexamethasone was required to maintain normal count of platelet. The careful and intensive management of ITP treatment is necessary in cases who show no response or relapse to initial glucocorticoids treatment. This is the first report about nivolumab-induced ITP and association with response to nivolumab in MPM.

Published
2020

27. Nivolumab-induced immune thrombocytopenia in a patient with malignant pleural mesothelioma

Author

1000050374278, Sakakibara-Konishi, Jun, Sato, Mineyoshi, Sato, Michiko Takimoto, Kasahara, Kohei, Onozawa, Masahiro, 1000040752689, Mizugaki, Hidenori, 1000060463741, Kikuchi, Eiki, 1000090374298, Asahina, Hajime, 1000020431372, Shinagawa, Naofumi, 1000020399835, Konno, Satoshi, 1000050374278, Sakakibara-Konishi, Jun, Sato, Mineyoshi, Sato, Michiko Takimoto, Kasahara, Kohei, Onozawa, Masahiro, 1000040752689, Mizugaki, Hidenori, 1000060463741, Kikuchi, Eiki, 1000090374298, Asahina, Hajime, 1000020431372, Shinagawa, Naofumi, 1000020399835, and Konno, Satoshi

Abstract

Malignant pleural mesothelioma (MPM) is a rare and highly aggressive tumor. Nivolumab showed durable antitumor effect in patients with recurrent MPM and was approved for those patients in Japan in 2018. Immune related adverse event (irAE) is occurred in various organs and is suggestive to be related to better outcome of nivolumab. Frequency of hematological irAE is low and there are few reports about hematological irAE and association between irAE and outcome of nivolumab in patients with MPM. We present a case of recurrent MPM who responded to nivolumab treatment and experienced nivolumab-induced immune thrombocytopenia (ITP). Although high dose dexamethasone was administered and platelet count increased transiently, re-administration of dexamethasone was required to maintain normal count of platelet. The careful and intensive management of ITP treatment is necessary in cases who show no response or relapse to initial glucocorticoids treatment. This is the first report about nivolumab-induced ITP and association with response to nivolumab in MPM.

Published
2020

28. Real-World Therapeutic Outcomes of S-1 Adjuvant Chemotherapy for pStage II/III Gastric Cancer in the Elderly

Author

Kunisaki, Chikara, primary, Sato, Sho, additional, Tsuchiya, Nobuhiro, additional, Kubo, Hirokazu, additional, Watanabe, Jun, additional, Sato, Tsutomu, additional, Takeda, Kazuhisa, additional, Tamura, Yuko, additional, Kasahara, Kohei, additional, Kosaka, Takashi, additional, Akiyama, Hirotoshi, additional, and Endo, Itaru, additional

Published
2021
Full Text
View/download PDF

33. Wilms Tumor 1 Expression at Diagnosis Correlates With Genetic Abnormalities and Polymorphism But Is Not Independently Prognostic in Acute Myelogenous Leukemia : AHokkaido Leukemia Net Study

Author

Hidaka, Daisuke, 1000070455632, Onozawa, Masahiro, Hashiguchi, Junichi, Miyashita, Naohiro, Kasahara, Kohei, Fujisawa, Shinichi, Hayase, Eiko, Okada, Kohei, 1000000645905, Shiratori, Souichi, Goto, Hideki, Sugita, Junichi, Nakagawa, Masao, Hashimoto, Daigo, Kahata, Kaoru, Endo, Tomoyuki, Yamamoto, Satoshi, Tsutsumi, Yutaka, Haseyama, Yoshihito, Nagashima, Takahiro, Mori, Akio, Ota, Shuichi, Sakai, Hajime, Ishihara, Toshimichi, Imai, Kiyotoshi, Miyagishima, Takuto, Kakinoki, Yasutaka, Kurosawa, Mitsutoshi, Kobayashi, Hajime, Iwasaki, Hiroshi, 1000000292029, Shimizu, Chikara, 1000070333606, Kondo, Takeshi, 1000040284096, Teshima, Takanori, Hidaka, Daisuke, 1000070455632, Onozawa, Masahiro, Hashiguchi, Junichi, Miyashita, Naohiro, Kasahara, Kohei, Fujisawa, Shinichi, Hayase, Eiko, Okada, Kohei, 1000000645905, Shiratori, Souichi, Goto, Hideki, Sugita, Junichi, Nakagawa, Masao, Hashimoto, Daigo, Kahata, Kaoru, Endo, Tomoyuki, Yamamoto, Satoshi, Tsutsumi, Yutaka, Haseyama, Yoshihito, Nagashima, Takahiro, Mori, Akio, Ota, Shuichi, Sakai, Hajime, Ishihara, Toshimichi, Imai, Kiyotoshi, Miyagishima, Takuto, Kakinoki, Yasutaka, Kurosawa, Mitsutoshi, Kobayashi, Hajime, Iwasaki, Hiroshi, 1000000292029, Shimizu, Chikara, 1000070333606, Kondo, Takeshi, 1000040284096, and Teshima, Takanori

Abstract

The association between Wilms tumor 1 (WT1) expression, genetic abnormalities and homozygous single polymorphism (SNP) in WT1 gene was evaluated in 252 acute myelogenous leukemia (AML) patients. WT1 expression correlated with prognostic genetic abnormalities. Homozygous WT1 SNP rs16754 was associated with lower expression of WT1. WT1 expression had no prognostic impact in any cytogenetic group or SNP status. Background: The prognostic impact of WT1 expression at diagnosis of acute myelogenous leukemia (AML) has been controversial. The aim of this study was to determine the correlations of WT1 expression at diagnosis of AML with established prognostic alterations. Patients and Methods: We analyzed diagnostic bone marrow samples from 252 patients. WT1 expression, SNP in WT1 gene (rs16754), and Flt3-ITD mutation were analyzed for all patients. NPM1 mutation and CEBPA double mutation were analyzed for cytogenetically normal (CN)-AML. KIT mutation was analyzed for core-binding factor (CBF)-AML. Results: Within the cytogenetically favorable prognosis group, WT1 expression in AML with inv(16) or t(15;17) was significantly higher than that in AML with t(8;21). In cases with CN-AML, Flt3-ITD and NPM1 mutations were both correlated with higher expression of WT1, whereas CEBPA double mutation was related to lower WT1 expression. The existence of both Flt3- ITD and NPM1 mutations showed synergistically higher expression of WT1 in CN-AML. SNP in WT1 gene (rs16754) was significantly associated with lower expression of WT1. WT1 levels were not prognostic factors in the total cohort, in any cytogenetic group nor SNP status. Conclusion: Since WT1 expression correlated to known prognostic factors, the prognostic impact of WT1 levels might be misunderstood depending on the distribution of collaborative mutations in each cohort. We conclude that the prognostic significance of WT1 at diagnosis of AML is weak compared to other established prognostic factors.

Published
2018

34. Effect of Lactobacillus casei strain Shirota-fermented milk on metabolic abnormalities in obese prediabetic Japanese men: a randomised, double-blind, placebo-controlled trial

Author

NAITO, Eiichiro, primary, YOSHIDA, Yasuto, additional, KUNIHIRO, Satoru, additional, MAKINO, Kumiko, additional, KASAHARA, Kohei, additional, KOUNOSHI, Yuu, additional, AIDA, Masanori, additional, HOSHI, Ryotaro, additional, WATANABE, Osamu, additional, IGARASHI, Tomoki, additional, MIYAZAKI, Kouji, additional, and ITO, Hideki, additional

Published
2018
Full Text
View/download PDF

36. Cytogenetically Unrelated Clones in Acute Myeloid Leukemia Showing Different Responses to Chemotherapy

Author

Kasahara, Kohei, Onozawa, Masahiro, Miyashita, Naohiro, Yokohata, Emi, Yoshida, Miho, Kanaya, Minoru, Kosugi-Kanaya, Mizuha, Takemura, Ryo, Takahashi, Shojiro, Sugita, Junichi, Shigematsu, Akio, Takahata, Mutsumi, Fujisawa, Shinichi, Hashimoto, Daigo, Fujimoto, Katsuya, Endo, Tomoyuki, Kondo, Takeshi, and Teshima, Takanori

Subjects
Article Subject, hemic and lymphatic diseases
Abstract

We report a case of acute myeloid leukemia (AML) with two cytogenetically unrelated clones. The patient was a 45-year-old male who was diagnosed with acute monoblastic leukemia (AMoL). Initial G-band analysis showed 51,XY,+6,+8,inv(9)(p12q13)c,+11,+13,+19[12]/52,idem,+Y[8], but G-band analysis after induction therapy showed 45,XY,-7,inv(9)(p12q13)c[19]/46,XY,inv(9)(p12q13)c[1]. Retrospective FISH analysis revealed a cryptic monosomy 7 clone in the initial AML sample. The clone with multiple trisomies was eliminated after induction therapy and never recurred, but a clone with monosomy 7 was still detected in myelodysplastic marrow with a normal blast percentage. Both clones were successfully eliminated after related peripheral blood stem cell transplantation, but the patient died of relapsed AML with monosomy 7. We concluded that one clone was de novo AMoL with chromosome 6, 8, 11, 13, and 19 trisomy and that the other was acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) with chromosome 7 monosomy showing different responses to chemotherapy. Simultaneous onset of cytogenetically unrelated hematological malignancies that each have a different disease status is a rare phenomenon but is important to diagnose for a correct understanding of the disease status and for establishing an appropriate treatment strategy.

Published
2016
Full Text
View/download PDF

37. The Prevalence of Cerebral Microbleeds in HIV-Infected Hemophilia Patients

Author

Endo, Tomoyuki, primary, Goto, Hideki, additional, Miyashita, Naohiro, additional, Ara, Takahide, additional, Kasahara, Kohei, additional, Okada, Kohei, additional, Shiratori, Soichi, additional, Sugita, Junichi, additional, Onozawa, Masahiro, additional, Hashimoto, Daigo, additional, Nakagawa, Masao, additional, Kahata, Kaoru, additional, Fujimoto, Katsuya, additional, Kondo, Takeshi, additional, Hashino, Satoshi, additional, Houkin, Kiyohiro, additional, and Teshima, Takanori, additional

Published
2017
Full Text
View/download PDF

39. Insulin receptor substrates form high-molecular-mass complexes that modulate their availability to insulin/insulin-like growth factor-I receptor tyrosine kinases

Author

Fukushima, Toshiaki, Arai, Toshiya, Ariga-Nedachi, Miyako, Okajima, Hiroshi, Ooi, Yuko, Iijima, Yumi, Sone, Meri, Cho, Yoshitake, Ando, Yasutoshi, Kasahara, Kohei, Ozoe, Atsufumi, Yoshihara, Hidehito, Chida, Kazuhiro, Okada, Shigeru, Kopchick, John J., Asano, Tomoichiro, Hakuno, Fumihiko, and Takahashi, Shin-Ichiro

Published
2011
Full Text
View/download PDF

42. A case of acquired colonic atresia in adult

Author

KASAHARA, Kohei, primary, NAGAMINE, Kotaro, additional, KAMEDA, Kunio, additional, SHIMA, Hidetaka, additional, FUJII, Kazuhiro, additional, KUBO, Akira, additional, and TAKEKAWA, Yoshinori, additional

Published
2013
Full Text
View/download PDF

43. Enhanced oxidative stress in GH-transgenic rat and acromegaly in humans

Author

Nishizawa, Hitoshi, primary, Handayaningsih, Anastasia-Evi, additional, Iguchi, Genzo, additional, Cho, Yoshitake, additional, Takahashi, Michiko, additional, Yamamoto, Masaaki, additional, Suda, Kentaro, additional, Kasahara, Kohei, additional, Hakuno, Fumihiko, additional, Yamanouchi, Keitaro, additional, Nishihara, Masugi, additional, Seino, Susumu, additional, Takahashi, Shin-Ichiro, additional, and Takahashi, Yutaka, additional

Published
2012
Full Text
View/download PDF

46. Ramucirumab Plus Paclitaxel as a Second-line Chemotherapy in Older Adults With Advanced Gastric Cancer (YCOG1601).

Author

Sato S, Kunisaki C, Tamura Y, Yago A, Kasahara K, Sato T, Kondo H, Kosaka T, Akiyama H, and Endo I

Subjects
Humans, Aged, Paclitaxel therapeutic use, Neoplasm Recurrence, Local drug therapy, Antineoplastic Combined Chemotherapy Protocols adverse effects, Ramucirumab, Stomach Neoplasms pathology, Adenocarcinoma pathology
Abstract

Background/aim: Ramucirumab plus paclitaxel has been widely used as a second-line chemotherapy for treating advanced gastric cancer. However, the real-world data of this regimen for older patients with gastric cancer (GC) remains unrevealed. The aim of this study was to clarify the feasibility and efficacy of this regimen for older patients with GC in a single-arm, phase II study., Patients and Methods: Patients aged ≥70 years having unresectable or recurrent GC who met the eligible criteria were enrolled. Paclitaxel was administered at a dose of 80 mg/m 2 on days 1, 8, and 15, and ramucirumab was administered at a dose of 8 mg/kg on day 1 and day 15 of a 4-week cycle. Primary endpoint was the incidence of adverse events and secondary endpoints were response rate, progression-free survival, and overall survival. A total of 25 patients were enrolled in the full-set analysis., Results: Grade 3 or more adverse events were observed in 21 patients (84.0%). Neutropenia was most frequently observed (68.0%), followed by peripheral sensory neuropathy (12.0%), and febrile neutropenia (12.0%). Median progression-free survival and overall survival were 6.9 months and 13.4 months, respectively. Disease control rate was 88.0%, and response rate of patients with measurable lesions was 52.9%. Notably, no treatment-related deaths occurred., Conclusion: Ramucirumab plus paclitaxel as a second-line chemotherapy demonstrated acceptable oncological outcomes, despite the occurrence of frequent adverse events. It is necessary to carefully select patients and adjust treatment regimens in older patients with GC to safely administer chemotherapy and subsequently achieve satisfactory long-term outcomes., (Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)

Published
2023
Full Text
View/download PDF

47. [Nutritional Status after Laparoscopic-Assisted Pylorus-Preserving Gastrectomy].

Author

Kasahara K, Kosaka T, Akiyama H, Tamura Y, Ishibe A, Kondo H, Sato S, Tanaka Y, Sato K, Sato T, Kunisaki C, and Endo I

Subjects
Gastrectomy, Humans, Nutritional Status, Postoperative Complications, Pylorus surgery, Retrospective Studies, Treatment Outcome, Laparoscopy, Stomach Neoplasms surgery
Abstract

Patients and Methods: Patients with gastric cancer who underwent laparoscopic-assisted pylorus-preserving gastrectomy (LAPPG group)or laparoscopic-assisted distal gastrectomy(LADG group)between January 2010 and December 2019 were reviewed and their postoperative nutritional status and long-term outcomes retrospectively evaluated., Results: In total, 83 patients(LAPPG group, n=23; LADG group, n=60)were included. Weight loss rates 1, 6, 12, and 24 months postoperatively in the LAPPG and LADG groups were 5.7% and 7.1%, 6.6% and 9.6%, 5.8% and 10.1%, and 5.2% and 8.7%, respectively. The LADG group exhibited a significantly higher weight loss than the LAPPG group at 6, 12, and 24 months (p=0.007, 0.002, and 0.022, respectively). No recurrence was observed in either group within 5 years of surgery. The 5- year overall survival rate of patients with pathological Stage Ⅰ cancer( LAPPG group, n=23, LADG group, n=51) was higher in the LAPPG group than in the LADG group(100% vs 82.9%, p=0.027). There were 6 cases of death from other diseases in the LADG group(pneumonia, n=2, other cancer, n=2, postoperative bleeding, n=1, and heart failure, n=1)but none in the LAPPG group., Conclusion: The weight loss after LAPPG was significantly lower than that after LADG. Furthermore, the former showed a good prognosis without death from other diseases, such as pneumonia.

Published
2021

48. [A Case of Rectal Metastasis from Breast Cancer Diagnosed Two Years after Surgery].

Author

Sazuka T, Miyazawa Y, Tochigi T, Hirano A, Mori M, Kosugi C, Shuto K, Kasahara K, Hiroshima Y, Matsuo K, Tanaka K, Yamazaki K, Koda K, and Matsubara H

Subjects
Biopsy, Needle, Breast Neoplasms drug therapy, Breast Neoplasms surgery, Fatal Outcome, Female, Humans, Middle Aged, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Breast Neoplasms pathology, Rectal Neoplasms drug therapy, Rectal Neoplasms secondary
Abstract

We report a case of rectal metastasis from breast cancer.Colorectal metastasis from breast cancer is sometimes difficult to diagnose before surgery.A transanal needle biopsy was thought to be useful for a diagnosis and selection of treatment method.

Published
2017

Catalog

Books, media, physical & digital resources
See catalog results